» Authors » Carmen Aguilar

Carmen Aguilar

Explore the profile of Carmen Aguilar including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 79
Citations 1036
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sabench F, Rusu E, Clavero-Mestres H, Arredondo-Prats V, Veciana-Molins M, Muniz-Piera S, et al.
Obes Surg . 2024 Nov; 34(12):4459-4471. PMID: 39560894
Background: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH) are increasingly prevalent in patients undergoing bariatric surgery (BS). Understanding their impact on weight loss outcomes after surgery...
2.
Bertran L, Rusu E, Aguilar C, Auguet T, Richart C
Dig Liver Dis . 2024 Nov; 57(2):526-534. PMID: 39532579
Background: Fatty acid esters of hydroxy fatty acids (FAHFAs) present potential beneficial effects that could offer valuable insights into metabolic and inflammatory diseases. However, few FAHFAs have been studied, and...
3.
Bertran L, Rusu E, Guirro M, Aguilar C, Auguet T, Richart C
J Proteomics . 2024 Sep; 310:105317. PMID: 39307454
In this study, we aimed to evaluate circulating proteomic levels in women with morbid obesity (MO) compared to normal-weight (NW) women. Moreover, we have compared the proteomic profile between women...
4.
Arto C, Rusu E, Clavero-Mestres H, Barrientos-Riosalido A, Bertran L, Mahmoudian R, et al.
Eur J Clin Invest . 2024 Jun; 54(11):e14279. PMID: 38940215
Background And Aims: The rise in obesity highlights the need for improved therapeutic strategies, particularly in addressing metabolic dysfunction-associated steatotic liver disease (MASLD). We aim to assess the role of...
5.
Bertran L, Capellades J, Abello S, Aguilar C, Auguet T, Richart C
PLoS One . 2024 May; 19(5):e0303569. PMID: 38743756
There is a phenotype of obese individuals termed metabolically healthy obese that present a reduced cardiometabolic risk. This phenotype offers a valuable model for investigating the mechanisms connecting obesity and...
6.
Pauzuolis M, Fatykhova D, Zuhlke B, Schwecke T, Neyazi M, Samperio-Ventayol P, et al.
Stem Cell Reports . 2024 Apr; 19(5):629-638. PMID: 38670110
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection primarily affects the lung but can also cause gastrointestinal (GI) symptoms. In vitro experiments confirmed that SARS-CoV-2 robustly infects intestinal epithelium. However,...
7.
Rusu E, Monfort-Lanzas P, Bertran L, Barrientos-Riosalido A, Sole E, Mahmoudian R, et al.
Comput Biol Med . 2024 Apr; 175:108507. PMID: 38657468
Background: Post COVID-19 Condition (PCC), characterized by lingering symptoms post-acute COVID-19, poses clinical challenges, highlighting the need to understand its underlying molecular mechanisms. This meta-analysis aims to shed light on...
8.
Duran-Bertran J, Rusu E, Barrientos-Riosalido A, Bertran L, Mahmoudian R, Aguilar C, et al.
Eur J Clin Invest . 2023 Nov; 54(3):e14123. PMID: 37929908
Background: There is a lack of noninvasive diagnostic methods for nonalcoholic steatohepatitis (NASH), the severe condition of metabolic dysfunction-associated steatotic liver disease (MASLD). Platelet activation, evaluated through certain related parameters,...
9.
Bertran L, Capellades J, Abello S, Duran-Bertran J, Aguilar C, Martinez S, et al.
Int J Mol Sci . 2023 Jun; 24(12). PMID: 37372937
This study investigated the importance of a metabolomic analysis in a complex disease such as nonalcoholic steatohepatitis (NASH) associated with obesity. Using an untargeted metabolomics technique, we studied blood metabolites...
10.
Auguet T, Bertran L, Capellades J, Abello S, Aguilar C, Sabench F, et al.
Int J Mol Sci . 2023 May; 24(9). PMID: 37175468
Obesity is a chronic and complex disease, with an increasing incidence worldwide that is associated with metabolic disorders such as type 2 diabetes mellitus (T2DM). Thus, it is important to...